TG Therapeutics, Inc. (TGTX) stock
TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3010% above fair value
$66.12+3.41 (+5.44%)
Close on Nov 18, 2026Market cap $10.12BP/E 24.1Yield –
TG Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
TG Therapeutics's total debt was $745.39M at Jun 30, 2026. For fiscal 2025 it was $245.65M, up 0.5% from the year before. The highest annual figure on record is $245.65M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $245.65M | +0.5% |
| FY2024 | Dec 31, 2024 | $244.43M | +144.1% |
| FY2023 | Dec 31, 2023 | $100.12M | +40.7% |
| FY2022 | Dec 31, 2022 | $71.14M | +5.0% |
| FY2021 | Dec 31, 2021 | $67.76M | +126.7% |
| FY2020 | Dec 31, 2020 | $29.90M | +3.2% |
| FY2019 | Dec 31, 2019 | $28.97M | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | – |
| FY2014 | Dec 31, 2014 | $0 | -100.0% |
| FY2013 | Dec 31, 2013 | $64.53K | -97.4% |
| FY2012 | Dec 31, 2012 | $2.48M | -24.8% |
| FY2011 | Dec 31, 2011 | $3.29M | -79.6% |
| FY2010 | Dec 31, 2010 | $16.13M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $745.39M | +204.2% |
| Q1 FY2026 | Mar 31, 2026 | $745.14M | +204.5% |
| Q4 FY2025 | Dec 31, 2025 | $245.65M | +0.5% |
| Q3 FY2025 | Sep 30, 2025 | $245.34M | +0.5% |
| Q2 FY2025 | Jun 30, 2025 | $245.04M | +139.0% |
| Q1 FY2025 | Mar 31, 2025 | $244.73M | +141.5% |
| Q4 FY2024 | Dec 31, 2024 | $244.43M | +144.1% |
| Q3 FY2024 | Sep 30, 2024 | $244.16M | +146.9% |
| Q2 FY2024 | Jun 30, 2024 | $102.54M | +5.0% |
| Q1 FY2024 | Mar 31, 2024 | $101.33M | +5.0% |
| Q4 FY2023 | Dec 31, 2023 | $100.12M | +40.7% |
| Q3 FY2023 | Sep 30, 2023 | $98.91M | +39.0% |
| Q2 FY2023 | Jun 30, 2023 | $97.70M | +41.7% |
| Q1 FY2023 | Mar 31, 2023 | $96.50M | +43.5% |
| Q4 FY2022 | Dec 31, 2022 | $71.14M | +5.0% |
| Q3 FY2022 | Sep 30, 2022 | $71.14M | +344.6% |
| Q2 FY2022 | Jun 30, 2022 | $68.95M | +197.7% |
| Q1 FY2022 | Mar 31, 2022 | $67.25M | +123.2% |
| Q4 FY2021 | Dec 31, 2021 | $67.76M | +126.7% |
| Q3 FY2021 | Sep 30, 2021 | $16.00M | -46.1% |
| Q2 FY2021 | Jun 30, 2021 | $23.16M | -21.3% |
| Q1 FY2021 | Mar 31, 2021 | $30.13M | +3.2% |
| Q4 FY2020 | Dec 31, 2020 | $29.90M | +3.2% |
| Q3 FY2020 | Sep 30, 2020 | $29.66M | +3.2% |
| Q2 FY2020 | Jun 30, 2020 | $29.43M | +3.2% |
| Q1 FY2020 | Mar 31, 2020 | $29.20M | +3.2% |
| Q4 FY2019 | Dec 31, 2019 | $28.97M | – |
| Q3 FY2019 | Sep 30, 2019 | $28.74M | – |
| Q2 FY2019 | Jun 30, 2019 | $28.51M | – |
| Q1 FY2019 | Mar 31, 2019 | $28.29M | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?